Tirzepatide is a dual GLP-1 and GIP receptor agonist it activates both pathways
The FDAs updated guidance The FDA issued a warning that compounded semaglutide may not be the same as Wegovy and Ozempic
If you have any underlying health conditions, you may also find that one medication works better for you than the other
Patients frequently experience reduced hunger and cravings, increased satiety, greater energy levels, and improved health markers like blood pressure and cholesterol
Wegovy FlexTouch is most effective when used alongside a reduced-calorie meal plan and increased physical activity
Initially, the US Food and Drug Administration approved Wegovy, the brand name for a GLP-1-based medicine called semaglutide, for chronic weight management in June 2021